In Vivo Therapeutics Spinal Cord Injury Therapy Tod

  • Slides: 11
Download presentation
In. Vivo Therapeutics Spinal Cord Injury Therapy Tod Holberton, Kent Leslie, Katie Yates

In. Vivo Therapeutics Spinal Cord Injury Therapy Tod Holberton, Kent Leslie, Katie Yates

Spinal Cord Anatomy • • http: //www. laesieworks. com/spinal/SCIinfo 01. html Attaches from brainstem

Spinal Cord Anatomy • • http: //www. laesieworks. com/spinal/SCIinfo 01. html Attaches from brainstem to vertebrae Two rows of nerve roots Sensory and motor nerve fibers Three meninges

Spinal Cord Injury • • • http: //www. michaelwaks. com/spinal-cord-injury-attorney. html 10, 000 people

Spinal Cord Injury • • • http: //www. michaelwaks. com/spinal-cord-injury-attorney. html 10, 000 people yearly Trauma damages vertebrae Vertebrae damage spinal cord Descending loss of function "Complete" and "Incomplete" injuries

Existing Treatments and Therapies • • http: //www. usahockey. com Methylprednisone Surgery Immobilization or

Existing Treatments and Therapies • • http: //www. usahockey. com Methylprednisone Surgery Immobilization or traction Occupational therapy

Scaffold Technology • PLGA Scaffold • 300 um pore size • Bioresorbable • Use

Scaffold Technology • PLGA Scaffold • 300 um pore size • Bioresorbable • Use of stem cells • Two different types of treatment for contusion vs. piercing injury http: //invivotherapeutics. com/pdf/In. Vivo_Investor_Presentation_3. 14. 13. pdf

Drug Releasing Polymer Technology • Scaffold implanted • • http: //physrev. physiology. org/content/87/1/315/F 7.

Drug Releasing Polymer Technology • Scaffold implanted • • http: //physrev. physiology. org/content/87/1/315/F 7. expansion. html with peroxynitrite scavenger Reduces neuroinflammatory NO free radicals Addresses the issue of secondary cell death

Procedure http: //www. invivotherapeutics. com/ourresearch/

Procedure http: //www. invivotherapeutics. com/ourresearch/

Effectiveness • • 2009 primate study Without treatment, loss of leg function With scaffold,

Effectiveness • • 2009 primate study Without treatment, loss of leg function With scaffold, animal is able to run on a treadmill and use its toes to grip and climb a ladder Greater injury recovery

Clinical Study • • • Hoping to begin clinical trials in 2013 Received HDE

Clinical Study • • • Hoping to begin clinical trials in 2013 Received HDE status from the FDA in April 2012 5 acute SCI patients at Brigham & Women's and Geisinger Hospital (PA) Rehab at Shepherd Center (GA) One-year followup

Cost, Complications, and Recovery Process • • • $60, 000 - $100, 000 Uncertainty

Cost, Complications, and Recovery Process • • • $60, 000 - $100, 000 Uncertainty of coverage No current recovery procedures for humans Technology still in the early developmental phase Only known complications thus far are those associated with invasive surgery

Future Developments • 510(k) approval for • • two neurological devices Expected to be

Future Developments • 510(k) approval for • • two neurological devices Expected to be on the market for late 2014 15 Billion potential market share